OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MEOBF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Mesoblast (MEOBF) Earnings Date & Reports

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MEOBF is expected to report earnings to fall 75.00% to 0 cents per share on November 26

Q3'25

Est.

$-0.01

Q2'25

Est.

$-0.04

Q4'24

Est.

$-0.01

Q3'24

Est.

$-0.01

Q4'23

Est.

$-0.02

The last earnings report on August 28 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 1.83K shares outstanding, the current market capitalization sits at 2.19B.

View a ticker or compare two or three

Compare

MEOBF

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MEOBF
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MEOBF showed earnings on August 28, 2025. You can read more about the earnings report here.

View AI-Driven Trading for MEOBF

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Level 38, 55 Collins Street

Phone

+61 396396036

Employees

Web

https://www.mesoblast.com